1,063
Views
0
CrossRef citations to date
0
Altmetric
Biochemistry, Cell and Molecular Biology

miR-137 overexpression protects neurons from Aβ-induced neurotoxicity via ERK1/2

, , , &
Pages 522-529 | Received 08 Jan 2021, Accepted 14 May 2021, Published online: 04 Jun 2021

References

  • Chong YH, Shin YJ, Lee EO, Kayed R, Glabe CG, Tenner AJ . 2006. ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures. J Biol Chem. 281:20315–20325. doi:10.1074/jbc.M601016200. 2006/05/23.
  • Collaborators GBDD. 2019. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global burden of disease study 2016. Lancet Neurol. 18:88–106. doi: 10.1016/S1474-4422(18)30403-4. 2018/12/01.
  • Devanna P, Vernes SC. 2014. A direct molecular link between the autism candidate gene RORa and the schizophrenia candidate MIR137. Sci Rep. 4:3994. doi: 10.1038/srep03994. 2014/02/07.
  • Duan J, Lu G, Li Y, Zhou S, Zhou D, Tao H.  2019. miR-137 functions as a tumor suppressor gene in pituitary adenoma by targeting AKT2. Int J Clin Exp Pathol. 12:1557–1564. 2020/01/15.
  • Erhard F, Haas J, Lieber D, Malterer G, Jaskiewicz L, Zavolan M, Dölken L, Zimmer R . 2014. Widespread context dependency of microRNA-mediated regulation. Genome Res. 24:906–919. doi:10.1101/gr.166702.113. 2014/03/29.
  • Gebert LFR, MacRae IJ. 2019. Regulation of microRNA function in animals. Nat Rev Mol Cell Biol. 20:21–37. doi: 10.1038/s41580-018-0045-7. 2018/08/16..
  • Giza DE, Vasilescu C, Calin GA. 2014. Key principles of miRNA involvement in human diseases. Discoveries (Craiova). 2:e34. doi: 10.15190/d.2014.26. 2015/09/01..
  • He E, Lozano MAG, Stringer S, Watanabe K, Sakamoto K, Oudsten FD, Koopmans F, Giamberardino SN, Hammerschlag A, Cornelisse LN et al. 2018. MIR137 schizophrenia-associated locus controls synaptic function by regulating synaptogenesis, synapse maturation and synaptic transmission. Hum Mol Genet. 27:1879–1891. doi: 10.1093/hmg/ddy089. 2018/04/11.
  • Huang C, Zhang X, Zheng J, Chen C, CHen Y, Yi J.  2014. Upregulation of miR-137 protects anesthesia-induced hippocampal neurodegeneration. Int J Clin Exp Pathol. 7:5000–5007. 2014/09/10.
  • Jiang Y, Xu B, Chen J, Sui Y, Ren L, Li J, Zhang H, Guo L, Sun X. 2018. Micro-RNA-137 inhibits Tau hyperphosphorylation in Alzheimer's disease and targets the CACNA1C gene in transgenic mice and human neuroblastoma SH-SY5Y cells. Med Sci Monit. 24:5635–5644. doi:10.12659/MSM.908765. 2018/08/14.
  • Kandratsenka H, Nestsiarovich A, Goloenko I, Danilenko N, Makarevich A, Obyedkov V, Davydenko O, Waszkiewicz N. 2018. Association of MIR137 With symptom severity and cognitive functioning in Belarusian schizophrenia patients. Front Psychiatry. 9:295. doi: 10.3389/fpsyt.2018.00295. 2018/07/22.
  • Kong Y, Liang X, Liu L, Zhang D, Wan C, Gan Z, Yuan L. 2015. High throughput sequencing identifies MicroRNAs mediating alpha-synuclein toxicity by targeting neuroactive-ligand receptor interaction pathway in early stage of drosophila Parkinson's disease model. PLoS One. 10:e0137432. doi: 10.1371/journal.pone.0137432. 2015/09/12.
  • Loohuis NF O, Ba W, Stoerchel PH, Kos A, Jager A, Schratt G, Martens GJM, van Bokhoven H, Kasri NN, Aschrafi A. 2015. MicroRNA-137 controls AMPA-receptor-mediated transmission and mGluR-dependent LTD. Cell Rep. 11:1876–1884. doi:10.1016/j.celrep.2015.05.040. 2015/06/23.
  • Mahmoudi E, Cairns MJ. 2017. MiR-137: an important player in neural development and neoplastic transformation. Mol Psychiatry. 22:44–55. doi: 10.1038/mp.2016.150. 2016/09/14.
  • Mayeux R, Stern Y. 2012. Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med. doi: 10.1101/cshperspect.a006239. 2 2012/08/22..
  • McIlwain DR, Berger T, Mak TW. 2013. Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol. 5:a008656. doi: 10.1101/cshperspect.a008656. 2013/04/03.
  • O'Brien J, Hayder H, Zayed Y, Peng C. 2018. Overview of MicroRNA biogenesis. Mech Actions Circ. Front Endocrinol (Lausanne). 9:402. doi: 10.3389/fendo.2018.00402. 2018/08/21.
  • Panza F, Lozupone M, Logroscino G, Imbimbo BP. 2019. A critical appraisal of amyloid-beta-targeting therapies for Alzheimer disease. Nat Rev Neurol. 15:73–88. doi: 10.1038/s41582-018-0116-6. 2019/01/06.
  • Reiss AB, Arain HA, Stecker MM, et al. 2018. Amyloid toxicity in Alzheimer's disease. Rev Neurosci. 29:613–627. doi: 10.1515/revneuro-2017-0063. 2018/02/16.
  • Roskoski R J. 2012. ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol Res. 66:105–143. doi:10.1016/j.phrs.2012.04.005. 2012/05/10.
  • Ryan TM, Caine J, Mertens HD, Kirby N, Nigro J, Breheney K, Waddington LJ, Streltsov VA, Curtain C, Masters CL, et al. 2013. Ammonium hydroxide treatment of Abeta produces an aggregate free solution suitable for biophysical and cell culture characterization. PeerJ. 1:e73. doi: 10.7717/peerj.73. 2013/05/17.
  • Sarachana T, Hu VW. 2013. Genome-wide identification of transcriptional targets of RORA reveals direct regulation of multiple genes associated with autism spectrum disorder. Mol Autism. 4:14. doi: 10.1186/2040-2392-4-14. 2013/05/24.
  • Subramaniam S, Unsicker K. 2010. ERK and cell death: ERK1/2 in neuronal death. FEBS J. 277:22–29. doi:10.1111/j.1742-4658.2009.07367.x. 2009/10/22.
  • Tan HL, Chiu SL, Zhu Q, Huganir RL. 2020. GRIP1 regulates synaptic plasticity and learning and memory. Proc Natl Acad Sci U S A. 117:25085–25091. doi: 10.1073/pnas.2014827117. 2020/09/20.
  • Tan HL, Queenan BN, Huganir RL. 2015. GRIP1 is required for homeostatic regulation of AMPAR trafficking. Proc Natl Acad Sci U S A. 112:10026–10031. doi: 10.1073/pnas.1512786112. 2015/07/29.
  • Volk L, Chiu SL, Sharma K, Huganir RL. 2015. Glutamate synapses in human cognitive disorders. Annu Rev Neurosci. 38:127–149. doi: 10.1146/annurev-neuro-071714-033821. 2015/04/22.
  • Wang M, Qin L, Tang B. 2019. MicroRNAs in Alzheimer's disease. Front Genet. 10:153. doi: 10.3389/fgene.2019.00153. 2019/03/19.
  • Wright C, Calhoun VD, Ehrlich S, Wang L, Turner JA, Perrone-Bizzozero NI. 2015. Meta gene set enrichment analyses link miR-137-regulated pathways with schizophrenia risk. Front Genet. 6:147. doi: 10.3389/fgene.2015.00147. 2015/05/06.
  • Zhu X, Li Y, Shen H, Li H, Long L, Hui L, Xu W. 2013. miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6. FEBS Lett. 587:73–81. doi:10.1016/j.febslet.2012.11.004. 2012/11/28.